EDQM Sets 2023 Target For Modernizing ‘Certificates Of Suitability’
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
You may also be interested in...
The European Directorate for the Quality of Medicines & HealthCare has launched a project to redesign its “certificates of suitability” to better respond to the needs of drug makers and regulatory authorities in terms of providing relevant information on active substances.
EU report on “lessons learnt” from the valsartan crisis calls for tighter GMP controls on API suppliers.
New treatments for advanced endometrial cancer and hereditary angioedema are among six drugs that have just been recommended for EU-wide approval. Harmonized EU advice has also been issued in relation to an investigational antibody combination for treating COVID-19.